Clinical Trials Directory

Trials / Completed

CompletedNCT00827450

Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet

Effects of Coffees With Various Compositions of Antioxidants on Hepatic Steatosis Induced by a High Fructose, Hypercaloric Diet

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Lausanne · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This study will assess * whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans * whether the protective effect of coffee is dependent on it's antioxidant composition

Detailed description

Epidemiological studies suggest that coffee consumption improves glucose homeostasis in insulin resistant subjects. An increase in intrahepatic lipids (hepatic steatosis) is highly prevalent in patients with the metabolic syndrome and may be used as a marker of altered hepatic lipid metabolism. Such an increased hepatic lipids content can be experimentally produced in healthy humans by a 6-day high fructose diet. The purpose of this study is to evaluate whether coffee prevents hepatic lipid deposition in healthy male subjects fed a fructose-rich hypercaloric diet. Both caffeine and antioxidants (yet unspecified) may be involved.. To sort out the role of caffeine and antioxidants, we will test 3 different soluble coffee, ie fully torrefied decaffeinated coffee , partially torrefied decaffeinated coffee, and partially torrefied caffeinated coffee.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCtlControl, isocaloric diet; no coffee
DIETARY_SUPPLEMENTHigh fructose diet; no coffeeHypercaloric, high fructose diet; no coffee
DIETARY_SUPPLEMENTfully torrefied, caffeine-free coffeeHypercaloric, high fructose diet + coffee
DIETARY_SUPPLEMENTpartially torrefied, caffeine-free coffeeHypercaloric, high fructose diet + coffee
DIETARY_SUPPLEMENTPartially torrefied, caffeinated coffeeHypercaloric, high fructose diet + coffee

Timeline

Start date
2009-02-01
Primary completion
2010-12-01
Completion
2011-03-01
First posted
2009-01-22
Last updated
2012-02-24

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00827450. Inclusion in this directory is not an endorsement.